%0 Journal Article
%T Novel therapeutic strategy for cervical cancer harboring FGFR3-TACC3 fusions
%A Cristine R. Casingal
%A Hiroaki Itamochi
%A Hirofumi Nakaoka
%A Hu Xin
%A Ituro Inoue
%A Juan Emmanuel Martšªnez-Ledesma
%A Kaoru Yamawaki
%A Kazuaki Suda
%A Kosuke Yoshihara
%A Masaaki Komatsu
%A Roel G. W. Verhaak
%A Ryo Tamura
%A Ryosuke Ishimura
%A Seiya Sato
%A Shujiro Okuda
%A Takayuki Enomoto
%A Tatsuya Ishiguro
%A Teiichi Motoyama
%A Tetsuya Saito
%A Yoichi Aoki
%A Yutaro Mori
%J Archive of "Oncogenesis".
%D 2018
%R 10.1038/s41389-017-0018-2
%X (a) Frequency of FGFR3-TACC3 fusion-positive cervical cancer in TCGA and Japanese datasets. Clinical information of FGFR3-TACC3 fusion-positive cervical cancer and two types of FGFR3-TACC3 fusion transcripts detected in the Japanese dataset are shown. b, c Scatter plot of FGFR3 and TACC3 mRNA expression in (b) TCGA dataset (n£¿=£¿306) or (c) Japanese dataset (n£¿=£¿103). FGFR3-TACC3 fusion-positive samples are highlighted in re
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5833787/